✉news HealthMedicine first seen 8 h ago, last 45 min ago, peak #37
Platform Trials Are Rewriting the Rules of Evidence
Original: Platform Trials Are Rewriting the Rules of Evidence. Regulators Haven’t Caught Up.
Platform trials, which test multiple treatments simultaneously against a shared control group, are increasingly used in medicine and are changing how clinical evidence is generated. Critics and commentators argue that drug regulators have not adapted their evaluation frameworks to this faster, more flexible trial design, raising questions about how such evidence should be assessed and approved.
Why now: Growing use of platform trials, highlighted during recent public health responses, has renewed debate over whether regulatory standards can keep pace.
drug regulatorspharmaceutical industryclinical researchers
Rank over time, top of the chart is #1. 7 snapshots from 8 h ago to 45 min ago.
Evidence
- Platform Trials Are Rewriting the Rules of Evidence. Regulators Haven’t Caught Up. · The Clinical Trial Vanguard
API: https://socialmediatrends-api.osmike.com/v1/trends/86921